Correlation Between CureVac NV and Boundless Bio,

Can any of the company-specific risk be diversified away by investing in both CureVac NV and Boundless Bio, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CureVac NV and Boundless Bio, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CureVac NV and Boundless Bio, Common, you can compare the effects of market volatilities on CureVac NV and Boundless Bio, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CureVac NV with a short position of Boundless Bio,. Check out your portfolio center. Please also check ongoing floating volatility patterns of CureVac NV and Boundless Bio,.

Diversification Opportunities for CureVac NV and Boundless Bio,

0.66

Correlation Coefficient

CureVac NV  Boundless Bio,

Poor diversification

The 3 months correlation between CureVac and Boundless is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding CureVac NV and Boundless Bio, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Boundless Bio, Common and CureVac NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CureVac NV are associated (or correlated) with Boundless Bio,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Boundless Bio, Common has no effect on the direction of CureVac NV i.e., CureVac NV and Boundless Bio, go up and down completely randomly.

Pair Corralation between CureVac NV and Boundless Bio,

Given the investment horizon of 90 days CureVac NV is expected to generate 1.14 times more return on investment than Boundless Bio,. However, CureVac NV is 1.14 times more volatile than Boundless Bio, Common. It trades about 0.02 of its potential returns per unit of risk. Boundless Bio, Common is currently generating about -0.18 per unit of risk. If you would invest  296.00  in CureVac NV on December 21, 2024 and sell it today you would earn a total of  1.00  from holding CureVac NV or generate 0.34% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

CureVac NV  vs.  Boundless Bio, Common

CureVac NV

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in CureVac NV are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, CureVac NV may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Boundless Bio, Common

Risk-Adjusted Performance

Very Weak

Over the last 90 days Boundless Bio, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with CureVac NV and Boundless Bio,

The main advantage of trading using opposite CureVac NV and Boundless Bio, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CureVac NV position performs unexpectedly, Boundless Bio, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boundless Bio, will offset losses from the drop in Boundless Bio,'s long position.

The idea behind CureVac NV and Boundless Bio, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..